These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19249128)

  • 1. Effects of amyloid-β peptides on the serotoninergic 5-HT1A receptors in the rat hippocampus.
    Verdurand M; Bérod A; Le Bars D; Zimmer L
    Neurobiol Aging; 2011 Jan; 32(1):103-14. PubMed ID: 19249128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of amyloid-beta 1-40 and 1-42 fibrils on 5-HT1A serotonin receptors in rat brain.
    Verdurand M; Chauveau F; Daoust A; Morel AL; Bonnefoi F; Liger F; Bérod A; Zimmer L
    Neurobiol Aging; 2016 Apr; 40():11-21. PubMed ID: 26973100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment.
    Truchot L; Costes SN; Zimmer L; Laurent B; Le Bars D; Thomas-Antérion C; Croisile B; Mercier B; Hermier M; Vighetto A; Krolak-Salmon P
    Neurology; 2007 Sep; 69(10):1012-7. PubMed ID: 17785670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
    J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET Neuroimaging Reveals Serotonergic and Metabolic Dysfunctions in the Hippocampal Electrical Kindling Model of Epileptogenesis.
    Bascuñana P; García-García L; Javela J; Fernández de la Rosa R; Shiha AA; Kelly J; Delgado M; Pozo MÁ
    Neuroscience; 2019 Jun; 409():101-110. PubMed ID: 31034972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT.
    Jagoda EM; Lang L; Tokugawa J; Simmons A; Ma Y; Contoreggi C; Kiesewetter D; Eckelman WC
    Synapse; 2006 May; 59(6):330-41. PubMed ID: 16440292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus.
    Zimmer L; Rbah L; Giacomelli F; Le Bars D; Renaud B
    J Nucl Med; 2003 Sep; 44(9):1495-501. PubMed ID: 12960198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.
    Vidal B; Sebti J; Verdurand M; Fieux S; Billard T; Streichenberger N; Troakes C; Newman-Tancredi A; Zimmer L
    Neuropharmacology; 2016 Oct; 109():88-95. PubMed ID: 27183968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats.
    Plenevaux A; Weissmann D; Aerts J; Lemaire C; Brihaye C; Degueldre C; Le Bars D; Comar D; Pujol J; Luxen A
    J Neurochem; 2000 Aug; 75(2):803-11. PubMed ID: 10899958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A postmortem study to compare agonist and antagonist 5-HT1A receptor-binding sites in Alzheimer's disease.
    Becker G; Streichenberger N; Billard T; Newman-Tancredi A; Zimmer L
    CNS Neurosci Ther; 2014 Oct; 20(10):930-4. PubMed ID: 25041947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
    Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of in vivo and in vitro neuroimaging of 5-HT 1A receptor binding sites in the cat brain.
    Aznavour N; Rbah L; Léger L; Buda C; Sastre JP; Imhof A; Charnay Y; Zimmer L
    J Chem Neuroanat; 2006 Apr; 31(3):226-32. PubMed ID: 16517120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease.
    Truchot L; Costes N; Zimmer L; Laurent B; Le Bars D; Thomas-Antérion C; Mercier B; Hermier M; Vighetto A; Krolak-Salmon P
    Neuroimage; 2008 Apr; 40(3):1251-6. PubMed ID: 18313943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo quantification of 5-HT1A-[18F]MPPF interactions in rats using the YAP-(S)PET scanner and a beta-microprobe.
    Millet P; Moulin M; Bartoli A; Del Guerra A; Ginovart N; Lemoucheux L; Buono S; Fagret D; Charnay Y; Ibáñez V
    Neuroimage; 2008 Jul; 41(3):823-34. PubMed ID: 18436452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.
    Laćan G; Plenevaux A; Rubins DJ; Way BM; Defraiteur C; Lemaire C; Aerts J; Luxen A; Cherry SR; Melega WP
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2256-66. PubMed ID: 18604533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of a radiosensitive intracerebral probe to monitor 18F-MPPF binding in mouse hippocampus in vivo.
    Desbrée A; Verdurand M; Godart J; Dubois A; Mastrippolito R; Pain F; Pinot L; Delzescaux T; Gurden H; Zimmer L; Lanièce P
    J Nucl Med; 2008 Jul; 49(7):1155-61. PubMed ID: 18552137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of the beta-Microprobe, an intracerebral radiosensitive probe, to monitor the [(18)F]MPPF binding in the rat dorsal raphe nucleus.
    Zimmer L; Pain F; Mauger G; Plenevaux A; Le Bars D; Mastrippolito R; Pujol JF; Renaud B; Lanièce P
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1237-47. PubMed ID: 12192569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampus 5-HT(1A)-receptors attenuate cocaine-induced hyperlocomotion and the increase in hippocampal but not nucleus accumbens 5-HT.
    Müller CP; Thönnessen H; Barros M; Tomaz C; Carey RJ; Huston JP
    Hippocampus; 2004; 14(6):710-21. PubMed ID: 15318330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
    Schechter LE; Smith DL; Rosenzweig-Lipson S; Sukoff SJ; Dawson LA; Marquis K; Jones D; Piesla M; Andree T; Nawoschik S; Harder JA; Womack MD; Buccafusco J; Terry AV; Hoebel B; Rada P; Kelly M; Abou-Gharbia M; Barrett JE; Childers W
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1274-89. PubMed ID: 15951399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.